Share

August 13, 2019; 93 (7) Disputes & Debates: Editors' Choice

Reader response: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial

Bernhard H.J. Juurlink, Ashton F. Embry, Pietro M. Bavera
First published August 12, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007956
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
23

Share

Article Information

vol. 93 no. 7 319-320
DOI: 
https://doi.org/10.1212/WNL.0000000000007956
PubMed: 
31405939
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published August 12, 2019.
Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Bernhard H.J. Juurlink,
    2. Ashton F. Embry and
    3. Pietro M. Bavera
  1. Bernhard H.J. Juurlink,
  2. Ashton F. Embry and
  3. Pietro M. Bavera
  1. (Saskatoon, Saskatchewan, Canada)
  2. (Calgary, Alberta, Canada)
  3. (Milan, Italy)
View Full Text

Article usage

Article usage: August 2019 to December 2022

AbstractFullPdfSource
Aug 20191352612Highwire
Sep 20193035Highwire
Oct 20191802Highwire
Nov 20192000Highwire
Dec 2019602Highwire
Jan 20201900Highwire
Feb 20201600Highwire
Mar 2020800Highwire
Apr 20201400Highwire
May 20201500Highwire
Jun 20201400Highwire
Jul 20201500Highwire
Aug 20205600Highwire
Sep 20203900Highwire
Oct 20203700Highwire
Nov 20202110Highwire
Dec 20201800Highwire
Jan 2021820Highwire
Feb 20211300Highwire
Mar 20211000Highwire
Apr 2021700Highwire
May 20211611Highwire
Jun 20211400Highwire
Jul 20211400Highwire
Aug 20211700Highwire
Sep 20211100Highwire
Oct 20211100Highwire
Nov 20212400Highwire
Dec 20211300Highwire
Jan 2022600Highwire
Feb 20223400Highwire
Mar 2022800Highwire
Apr 2022500Highwire
May 2022500Highwire
Jun 2022800Highwire
Jul 2022701Highwire
Aug 20221110Highwire
Sep 20221410Highwire
Oct 2022700Highwire
Nov 20221000Highwire
Dec 2022700Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me